PMC:7461420 / 77462-77610 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7461420","sourcedb":"PMC","sourceid":"7461420","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7461420","text":"Compound 159 displayed the best inhibitory activity of PLpro (IC50, 0.6 µM) and acts in a noncovalent reversible manner with a K i value of 0.49 µM.","tracks":[{"project":"LitCovid-PD-CLO","denotations":[{"id":"T912","span":{"begin":43,"end":51},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T913","span":{"begin":88,"end":89},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T914","span":{"begin":125,"end":126},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"attributes":[{"subj":"T912","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T913","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T914","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T670","span":{"begin":0,"end":148},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T670","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CLO","color":"#93ec93","default":true},{"id":"LitCovid-sentences","color":"#ec93ac"}]}]}}